Columbus Circle Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-84,232
| Closed | -$7.84M | – | 183 |
|
|
2017
Q3 | $7.84M | Sell |
84,232
-16,548
| -16% | -$1.54M | 0.13% | 149 |
|
|
2017
Q2 | $9.15M | Sell |
100,780
-157,202
| -61% | -$14.3M | 0.15% | 131 |
|
|
2017
Q1 | $22.6M | Sell |
257,982
-50,108
| -16% | -$4.4M | 0.32% | 90 |
|
|
2016
Q4 | $25.5M | Buy |
308,090
+39,497
| +15% | +$3.27M | 0.33% | 82 |
|
|
2016
Q3 | $24.9M | Buy |
268,593
+90,238
| +51% | +$8.35M | 0.27% | 86 |
|
|
2016
Q2 | $13.9M | Sell |
178,355
-43,303
| -20% | -$3.37M | 0.14% | 143 |
|
|
2016
Q1 | $18.3M | Sell |
221,658
-42,341
| -16% | -$3.49M | 0.16% | 128 |
|
|
2015
Q4 | $27.7M | Buy |
263,999
+37,615
| +17% | +$3.94M | 0.22% | 103 |
|
|
2015
Q3 | $23.8M | Buy |
226,384
+10,384
| +5% | +$1.09M | 0.2% | 111 |
|
|
2015
Q2 | $29.5M | Sell |
216,000
-138,487
| -39% | -$18.9M | 0.21% | 119 |
|
|
2015
Q1 | $44.2M | Sell |
354,487
-96,327
| -21% | -$12M | 0.3% | 87 |
|
|
2014
Q4 | $40.8M | Sell |
450,814
-219,490
| -33% | -$19.8M | 0.29% | 85 |
|
|
2014
Q3 | $48.4M | Sell |
670,304
-188,992
| -22% | -$13.6M | 0.35% | 74 |
|
|
2014
Q2 | $53.5M | Buy |
859,296
+218,447
| +34% | +$13.6M | 0.37% | 81 |
|
|
2014
Q1 | $43.7M | Buy |
640,849
+232,959
| +57% | +$15.9M | 0.29% | 93 |
|
|
2013
Q4 | $28.7M | Buy |
407,890
+26,047
| +7% | +$1.83M | 0.2% | 131 |
|
|
2013
Q3 | $27.6M | Sell |
381,843
-338,212
| -47% | -$24.4M | 0.2% | 133 |
|
|
2013
Q2 | $40.1M | Buy |
+720,055
| New | +$40.1M | 0.32% | 86 |
|